REX American Resources/$REX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About REX American Resources

REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.

Ticker

$REX
Sector

Primary listing

NYSE

Employees

122

REX Metrics

BasicAdvanced
$1B
20.50
$1.49
0.68
-

What the Analysts think about REX

Analyst ratings (Buy, Hold, Sell) for REX American Resources stock.

Bulls say / Bears say

As of April 30, 2025, REX had $315.9 million in cash, cash equivalents, and short-term investments with zero bank debt, ensuring strong liquidity to support its expansion projects (SEC).
REX bought back about 822,256 shares for $32.7 million in Q1 2025, representing 4.7% of its outstanding shares, with total repurchases reaching 6.8% since December 2024. This highlights management’s focus on shareholder returns (SEC).
The company posted its 19th consecutive quarter of positive earnings in Q1 FY25, showing steady profitability in its main ethanol business despite market fluctuations (SEC).
Net income attributable to REX shareholders fell to $8.7 million in Q1 2025, compared to $10.2 million in Q1 2024, leading to EPS declining to $0.51 from $0.58 year-over-year (SEC).
In Q2 FY25, gross profit dropped to $14.3 million from $19.8 million in Q2 FY24, indicating margin pressure due to lower co-product pricing even though ethanol volumes rose (Investors).
REX’s Q2 FY25 diluted EPS decreased to $0.43 from $0.70 in the prior year, as net income declined to $7.1 million from $12.4 million, reflecting tightening margins (Investors).
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.

REX Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

REX Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $REX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs